EWTX SG&A Expense Growth
Edgewise Therapeutics Inc · SG&A Expense Growth
EWTX SG&A Expense Growth
Latest reported25.58%period ending
EWTX FY SG&A Growth (YoY) (0.00% → 25.58%)
Latest values, visible window
High-resolution chart · PNG
EWTX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 25.579% | |
| 35.8775% | |
| 33.0534% | |
| 59.8585% | |
| 399.1399% | |
| 69.9231% | |
| 0% |